The shortage of deceased organ donors has created a need for right lobe living donor liver transplantation in adults.
Concerns regarding donor safety, however, necessitate continuous assessment of donor acceptance criteria and documentation of donor morbidity.
Dr Mark Cattral and colleagues report on the outcomes of the first 101 donors who underwent right lobectomy between 2000 and 2004.
The cohort comprised 58 men and 43 women with a median age of 38 years and a median follow-up of 24 months.
The middle hepatic vein was taken with the graft in 55 donors.
| The overall morbidity rate was 37%|
|American Journal of Transplantation|
The research team recorded all complications prospectively and stratified them by grade according to Clavien's classification.
The team noted that the overall morbidity rate was 37%.
All complications were either grade 1 or 2, and the majority occurred during the first 30 days after surgery.
The research team observed that the removal of the middle hepatic vein did not affect morbidity rate.
There were significantly fewer complications in the later half of our experience.
The researchers reported that all donors are well and have returned to full activities.
Dr Cattral's team concludes, “With careful donor selection and specialized patient care, low morbidity rates can be achieved after right hepatectomy for living donor liver transplantation.”